Stock CORT CORCEPT THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Corcept Therapeutics Incorporated

Equities

CORT

US2183521028

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
22.8 USD +2.66% Intraday chart for Corcept Therapeutics Incorporated -0.65% -29.80%
Apr. 22 Corcept Therapeutics Incorporated Announces Positive Results from Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients with Cushing?s Syndrome CI
Apr. 15 Corcept Completes Enrollment in Phase 2 Dazals Trial in Patients with Amyotrophic Lateral Sclerosis CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CORT Stock
  4. Revisions Corcept Therapeutics Incorporated